Announcements

Date	Title
09 Sep 24, 11:30	Ananda Developments - WRAP Retail Offer for up to £100,000	View
09 Sep 24, 10:30	Ananda Developments - Placing and Subscription to raise c.£2.15 million	View
29 Aug 24, 08:00	Ananda Developments - Launch of CBD Whitepaper	View
29 Aug 24, 07:00	Ananda Developments - Management accounts for quarter ended 31 July 2024	View
09 Aug 24, 10:56	Ananda Developments - Result of AGM	View
05 Aug 24, 07:00	Ananda Developments - Graduation to Apex segment of AQSE Growth Market	View
16 Jul 24, 07:00	Ananda Developments - Notice of AGM	View
15 Jul 24, 07:00	Ananda Developments - Publication of Annual Report and Accounts	View
11 Jul 24, 07:00	Ananda Developments - Invitation to Investor Evening	View
26 Jun 24, 07:00	Ananda Developments - Promising Results from Cardiac Fibrosis Studies	View
11 Jun 24, 13:27	Ananda Developments - Extension of Mark Ling as Senior Statutory Auditor	View
31 May 24, 07:00	Ananda Developments - Ananda joins cannabinoid R&D Group	View
30 May 24, 07:00	Ananda Developments - Quarterly Trading Statement to 30 April 2024	View
14 May 24, 07:00	Ananda Developments - Ananda Presentation to LSX Conference 2024	View
02 May 24, 12:00	Ananda Developments - Response to FSA-FSS Cannabidiol Safety Assessment	View
21 Mar 24, 07:00	Ananda Developments - Establishment of Scientific Advisory Board	View
28 Feb 24, 07:00	Ananda Developments - Endometriosis Trial Drug Supply Agreement Signed	View
26 Feb 24, 12:00	Ananda Developments - Ananda presenting at Master Investor Show	View
26 Feb 24, 07:00	Ananda Developments - Quarterly Trading Statement to 31 January 2024	View
06 Feb 24, 07:00	Ananda Developments - Appointment of Adviser	View